[PDF][PDF] Guevara Rios E

J Pacheco-Romero… - Butrica Ferré, N …, 2021 - pdfs.semanticscholar.org
Background: Preeclampsia is a multiorgan disorder associated with maternal and perinatal
morbimortality. In Peru, incidence is 10% and accounts for 22% of maternal deaths. Genome …

[PDF][PDF] Иммуномодулятор аминодигидрофталазиндион как компонент патогенетической терапии пациентов с гипертонической болезнью с астеническим …

НВ Стрижова - 2021 - sechenov.ru
По данным экспертов ВОЗ, среди взрослого населения земного шара повышение АД
встречается у 20% и только у каждого пятого больного достигаются нормальные …

D Vitamini Eksikliği Olan Yetişkinlerde Paraoksonaz ve Arilesteraz Aktiviteleri

FA Baylan, M Kılınç, Y Doboğlu, H Sağer - Sakarya Tıp Dergisi - dergipark.org.tr
Objective: The aim of this study was to evaluate paraoxonase (PON-1) and arylesterase
(ARE) enzyme activity and to evaluate the relationship between vitamin D level and serum …

Proprotein Convertase Subtilisin/Kexin Type 9: Functional Role in Lipid Metabolism and Its Therapeutic Inhibition

PP Toth - Therapeutic Lipidology, 2021 - Springer
Proprotein convertase/kexin type 9 (PCSK9) is produced and secreted by hepatocytes. Once
in the extracellular milieu, PCSK9 can bind to the low-density lipoprotein receptor (LDLR) …

[PDF][PDF] Lipoprotein (a) as a Risk Factor for Atherosclerotic Peripheral Arterial Occlusive Disease

BA Kothari, KR Bhagavan, L Lobo, N Kumar… - Journal of, 2021 - researchgate.net
Background and Aim: Peripheral arterial occlusive disease (PAOD) commonly results from
progressive narrowing of arteries in the lower extremities due to atherosclerosis. The …

[PDF][PDF] Novel Inflammatory Biomarkers as Additional Value to Traditional Risk-factors in Cardiovascular Risk Stratification. Open Access Maced J Med Sci. 2020 Nov …

A Vavlukis, M Vavlukis, A Dimovski, G Petrushevska… - 2020 - academia.edu
BACKGROUND:: There is a growing interest in the possible role of inflammatory biomarkers,
such as interleukins, chemokines, growth factors, and acute-phase proteins, in …

Biomarkers of subclinical atherosclerosis

EN SANCHEZ, JV Cobos, V Fuster… - US Patent App. 17 …, 2022 - Google Patents
US20220187312A1 - Biomarkers of subclinical atherosclerosis - Google Patents
US20220187312A1 - Biomarkers of subclinical atherosclerosis - Google Patents …

Method for estimating the effectiveness of treatment with an anti-cd20 agent in a patient with rheumatoid arthritis and having had an inadequate response to at least …

P Gaudin, A Baillet, A Courtier… - US Patent App. 17 …, 2022 - Google Patents
The present invention relates to a method for estimating the effectiveness of treatment with
an anti-CD20 agent in a patient with rheumatoid arthritis and who has had an inadequate …

[PDF][PDF] Lipoprotein (a) and Calcific Aortic Valve Stenosis

CE Kosmas, D Silverio, A Sourlas - EMJ, 2019 - emjreviews.com
Calcific aortic valve stenosis is the most common valve disease in the elderly population and
is associated with significant morbidity and mortality. This condition is characterised by …

Lp (a): der akzeptierte unabhängige Risikofaktor

V Schettler - Dialyse aktuell, 2019 - thieme-connect.com
Lipoprotein (a)(Lp (a)) besteht aus einem LDL-Partikel, an dem über das Apolipoprotein
B100 des Partikels eine Disulfidbrücke zu einem Apolipoprotein (a) besteht (Abb. 1) …